Integration is fully underway after the merger last year between the two German ingredient giants, Cognis and BASF, with projects developing under the newly formed Human Nutrition unit in the wake of BASF’s €3bn acquisition in December, 2010.
The newly-acquired Cognis business had a positive effect on BASF’s Q1 Performance Products results, as the integration is on-track for completion by the end of 2011.
Nine months after the European Food Safety Authority (EFSA) handed in a positive safety assessment for conjugated linoleic acid (CLA), the weight management ingredient will be assessed by the European Commission as it continues its protracted journey...
Cognis says it is following a “dual pillar” approach to product marketing that involves stressing market awareness of health benefits for some ingredients such as plant extracts, rather than investing in EFSA (European Food Safety Authority) submissions.
Cognis is trawling through this week’s article 13.1 claims with a fine tooth comb, after noting that the opinions on CLA do not appear to address its main marketing angle, on body fat reduction.
‘Billion dollar deal’ was not a phrase bandied about the food ingredients industry much last year. With BASF buying Cognis for €3.1bn and Corn Products International paying $1.3bn for National Starch, M&A looks to be thawing – but best not get over-excited...
BASF’s €3.1bn buy-out of Cognis is driven by interest in all of the German company’s three divisions – personal care, household chemical and human nutrition – but although human nutrition is the smallest part of the acquired operation, it was vital to...
Speculation about typical asset valuing ion the chemicals industry by Cognis’s chief financial officer, Marco Panichi, has led to a figure of €3.4bn being attached to the German ingredient company, as buy-out speculation mounts.
Improved logistics and optimised process control technology resulting from a multi million euro investment in its Danish microencapsulation facility will allow greater flexibility in terms of carotenoid and vitamin powder delivery to manufacturers, claims...
Cognis claims to have steered a steady course through last year’s economic upheaval. But despite a return to profitability, the downturn took its toll on nutrition and health and care ingredients sales.
German ingredients giant, Cognis, has signed up two ingredients from its biotech partner, InterMed Discovery (IMD), that have demonstrated weight management and heart health benefits.
Cognis has told NutraIngredients.com the German ingredients giant will not be sold in the near-future despite suggestive statements emanating from the German press.
Cognis has won hard-to-come-by approval from the Australian Thepareutic Goods Administration (TGA) to use its anti-cholesterol, plant sterol ester ingredient, Vegepure, in food supplements.
German ingredients giant Cognis has attained an ISO (International Standards Organisation) grading for a facility that produces sterol esters, CLA (conjugated linoleic acid) and fish oils.
German ingredients giant Cognis has gained access to one of the
world's largest natural compounds databases in a move it hopes will
generate business in new functional foods, supplements and
cosmeceutical applications.
Cognis has expanded its sterol ester plant in Germany, enabling the
global chemicals supplier to produce the functional foods
ingredient in a finished form without any further processing
needed.
Cognis has reported strong sales and operating profits for full
year 2006 - results to which its wellness and sustainability focus
made significant contribution.
Cognis has announced it will launch a branded omega-3 fish oil
ingredient called Omevital, following its acquisition of the
Norwegian supplier Napro Pharma earlier this year.
Cognis is tailoring some of its branded health ingredients around
an immunity platform directed at the cold and flu season
specifically, the company announced at Supply Side West in Las
Vegas.
Cognis has refused to confirm reports in the German press that it
is in advanced discussions with three potential purchasers, but the
outcome of a strategic review will be made public before the end of
the year.
Puleva Biotech has signed an agreement with US-based The Wright
Group for its Eupoly fish oils to be used in a new line of
microencapsulated powders, becoming the latest supplier to shore up
its presence in an ever more crowded market.
Cognis and WILD are joining forces to form a powerhouse of food and
beverage product innovation, combining Cognis' store of ingredients
with Wild's formulation expertise.
Cognis has announced its first move in the competitive omega-3
market with the acquisition of Norwegian fish oil concentrate
supplier Napro Pharma, and is developing new solutions to aid its
use in foods.
Cognis is counting on phytosterols and branded ingredients like
Tonalin CLA to drive its nutrition and health business unit, while
at the same time investigating strategic options for the company as
a whole
Health ingredients firm Cognis has introduced two African plant
extracts that it claims can offer real antioxidant benefits to iced
tea and other drinks looking for a healthy positioning.
German health ingredients firm Cognis Nutrition & Health will
introduce a new range of high quality plant extracts for foods and
beverages at Vitafoods, the industry show opening in Geneva
tomorrow.
Stronger demand for chemicals lifted sales across all business
units at Cognis, the Germany company said this week, with one of
the best performances from its health ingredients division
confirming the group's focus on wellness,...
Cognis Nutrition & Health is introducing a vegetarian version
of its marigold-derived Xangold 10% microencapsulated lutein ester
beadlets for tablet and dry food formulators seeking to meet the
needs of a burgeoning vegetarian...
German group Cognis, the supplier of plant sterols and CLA, is
considering the issue of a €500 million bond to fund a dividend
payment to its private equity owners, it said last week.
The first half of 2004 has brought some light relief for Cognis'
Nutrition and Health division, which suffered from adverse currency
movements last year.
Cognis, the speciality chemicals company, suffered a tough year in
the nutritional ingredients market, with a long-awaited surge in
the growth of its natural vitamin E sales undermined by adverse
currency movements.
Cognis Nutrition and Health has added a new vegetable sterol esters
ingredient to its product range. The company, which launched the
product for the US market at the SupplySide West tradeshow last
week, said vegetable sterol esters...
The Cognis Group, a leader in antioxidant and botanical
ingredients, announced recently that it is near to completing
construction of the world's largest stand-alone manufacturing
facility for phytosterols.
First half sales at speciality chemicals group Cognis dropped to
around €1.5 billion, significantly lower than last year's €1.6
billion, but the firm claims it achieved growth in almost all units
exluding the impact of the exchange...
Always one of the biggest stands at Vitafoods, Cognis Nutrition and
Health seem ever more present this year, with heavy marketing,
including an evening event, to launch its Tonalin CLA to the
European market.
Speciality chemicals company Cognis yesterday reported its
operating result before EBITDA rose 3 per cent to €393 million for
2002, despite flat sales during the year.
Cognis Nutrition & Health, a nutritional ingredients supplier,
has responded to claims made earlier this week by Dutch rival
Loders Croklaan regarding the infringement of several of its
patents.
Speciality chemicals company Cognis announced today that its
agreement with Norwegian firm Natural for the licence to its
Tonalin brand conjugated linoleic acid (CLA) will go into effect
this weekend.
Speciality chemicals group Cognis reported sales for the first nine
months of the year on a level with last year's figure, rising by a
mere 1 per cent to €2,408 million. A better-than-average
performance came from the nutrition...
Cognis Nutrition and Health and Kemin Foods have finally reached an
agreement in court over the marketing and promotional issues for
lutein and lutein esters products.Specific terms of the agreement
are to remain confidential between...
Specialty chemicals company Cognis said it had maintained its
market position in 2001 despite difficult trading conditions and
the sale of the company in November.
Natural specialty ingredients manufacturer Kemin Foods, has filed a
lawsuit in the US contending that fine chemicals company, Cognis
Corp., continues to make false claims that blur the differences
between lutein esters and the purified...
Henkel KgaA has agreed to sell its chemical division Cognis to a
consortium of financial investors comprising of Schroder Ventures
and Goldman Sachs Capital Partners.
